Tuesday, July 17, 2018
Big news hit the pharmaceutical industry in February when Roche Pharmaceuticals announced that it would be acquiring big-data firm Flatiron Health for $1.9 billion. Roche already held a 12% stake in Flatiron, so the total value of the deal--which was...
A new cancer center model is helping meet the demand for better quality cancer care in community settings, and ADC Review | Journal of Antibody-drug Conjugates has an original paper describing the concept. Hybrid academic-community cancer centers began emerging...
A randomized clinical trial of 766 patients, funded by the Conquer Cancer Foundation of the American Society of Clinical Oncology (ASCO), shows that a simple, web-based, tool that enables patients to report their symptoms in real time, improves outcomes....
The U.S. Food and Drug Administration (FDA) has approved a supplemental biologics license application orsBLA for obinutuzumab (Gazyva®; Genentech/Roche) in combination with chlorambucil chemotherapy in people with previously untreated chronic lymphocytic leukemia (CLL). The sBLA adds to the label...
Data from a new analysis published early online in Cancer, a peer-reviewed journal of the American Cancer Society has found that while clinical trial data support omitting radiation treatments in elderly women with early stage breast cancer, nearly two-thirds...
There has been a real revolution in the understanding of molecular biology. This revolution is fueled by the rapid decline in the costs of sequencing, which allowed next-generation sequencing (NGS) assays, previously only seen in research laboratories, to begin...
A new study first published online in the October 29, 2014 issue of BJU International, has found that certain prostate cancer medications are linked with an increased risk of dying from heart-related causes in men with congestive heart failure...
Prostate cancer is among the most prevalent cancers in the developed world. It also remains one of the most complex diseases to treat. According to the American Cancer Society prostate cancer is a leading cause of cancer-related deaths. While...
A deadly disease. You may think you can’t get it. But it can happen to anybody. How to cope? In September 2000, one week before turning 32, Hazel Flynt, a specialist in the study of patient-centered care, crashed into...
When Jennifer Madelyn Trichot was diagnosed with stage III epithelial ovarian cancer it was like she was dealt a death sentence. “For the first time I was confronted with my mortality,” Trichot recalls. I did not understand the disease...

Related articles